Stocks and Investing Stocks and Investing
Tue, February 21, 2023
[ 12:00 AM ] - WOPRAI
Colin Rusch Maintained (ALB) at Buy with Increased Target to $498 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
David Toung Maintained (SYK) at Strong Buy with Increased Target to $285 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Spiro Dounis Maintained (SUN) at Hold with Increased Target to $48 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (SQ) at Hold with Increased Target to $67 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Maheep Mandloi Maintained (STEM) at Buy with Decreased Target to $20 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Brian Kleinhanzl Maintained (STEM) at Strong Buy with Decreased Target to $14 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Ki Bin Kim Maintained (SPG) at Hold with Increased Target to $130 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Gaurav Jain Maintained (SMG) at Buy with Increased Target to $105 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Michael Rose Downgraded (CFR) to Hold on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Paul Zimbardo Downgraded (CEG) to Hold and Decreased Target to $88 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
James Thalacker Maintained (CEG) at Buy with Decreased Target to $93 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Lauren Lieberman Maintained (CCEP) at Buy with Decreased Target to $67 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Eric Beder Reiterated (BWMX) at Strong Buy and Held Target at $15 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Ike Boruchow Maintained (BURL) at Buy with Increased Target to $275 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Increased Target to $79 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Bill Katz Maintained (BRDG) at Hold with Increased Target to $15 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Suneet Kamath Maintained (BHF) at Hold with Increased Target to $60 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (BFAM) at Buy with Decreased Target to $81 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
George Tong Maintained (BFAM) at Strong Buy with Decreased Target to $82 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Michael Ciarmoli Maintained (B) at Hold with Increased Target to $40 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Joseph Stringer Reiterated (APLS) at Strong Buy with Increased Target to $80 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Douglas Tsao Reiterated (APLS) at Strong Buy and Held Target at $87 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Yigal Nochomovitz Maintained (APLS) at Strong Buy with Increased Target to $91 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Colleen Kusy Maintained (APLS) at Buy with Increased Target to $105 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Annabel Samimy Maintained (APLS) at Strong Buy with Increased Target to $75 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Kyle White Maintained (ATR) at Strong Buy with Increased Target to $130 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Ghansham Panjabi Maintained (ATR) at Hold with Increased Target to $115 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Gabe Hajde Maintained (ATR) at Buy with Increased Target to $132 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (ATNM) at Strong Buy and Held Target at $53 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Andy Hsieh Downgraded (ATNM) to Hold on, Feb 21st, 2023

Andy Hsieh Downgraded (ATNM) to Hold on, Feb 21st, 2023


Published on 2024-10-28 01:46:03 - WOPRAI, Andy Hsieh
  Print publication without navigation


Andy Hsieh of William Blair, Downgraded "Actinium Pharmaceuticals, Inc." (ATNM) to Hold on, Feb 21st, 2023.

Andy has made no other calls on ATNM in the last 4 months.



There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Andy's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andy

  • Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $18 on, Monday, October 31st, 2022
Contributing Sources